» Articles » PMID: 3679543

Influence of Staphylococcus Aureus Antibody on Experimental Endocarditis in Rabbits

Overview
Journal Infect Immun
Date 1987 Dec 1
PMID 3679543
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the potential protective benefit of antibody to whole cells of Staphylococcal aureus for the prevention of endocarditis, the rabbit endocarditis model was used. Methicillin-sensitive (17A) and methicillin-resistant (173) S. aureus strains were evaluated in rabbits with or without indwelling intracardiac catheters. All immunized rabbits developed significant homologous agglutinating antibody titers (the mean reciprocal titers were 15,300 to strain 17A and 1,150 to strain 173). After challenge, virtually no significant differences were observed between immunized and unimmunized animals with respect to (i) incidence of endocarditis, (ii) concentration of bacteria in infected vegetations, (iii) incidence of metastatic renal abscesses, or (iv) concentrations of bacteria in infected kidneys. The clearance of homologous S. aureus strains from blood cultures was similar for immunized and unimmunized animals at 10 to 90 min after intravenous challenge. In vivo adherence of homologous S. aureus strains to aortic valves and vegetations was similar in immunized and unimmunized animals when evaluated at 30 and 90 min postchallenge. Even without catheterization, the incidence of bacteremia and renal abscesses was the same in immunized and unimmunized rabbits. Whole-cell-induced S. aureus antibody did not prevent or modify any stage in the development of endocarditis in rabbits.

Citing Articles

Infective endocarditis.

Holland T, Baddour L, Bayer A, Hoen B, Miro J, Fowler Jr V Nat Rev Dis Primers. 2016; 2:16059.

PMID: 27582414 PMC: 5240923. DOI: 10.1038/nrdp.2016.59.


A rabbit model of right-sided Staphylococcus aureus endocarditis created with echocardiographic guidance.

Wang M, Zhang Y, Fan M, Guo Y, Ren W, Luo E Cardiovasc Ultrasound. 2013; 11:3.

PMID: 23317050 PMC: 3598207. DOI: 10.1186/1476-7120-11-3.


Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Bronze M, Dale J Am J Med Sci. 2010; 340(3):218-25.

PMID: 20697258 PMC: 2935929. DOI: 10.1097/MAJ.0b013e3181e939ab.


Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.

Brown M, Kowalski R, Zorman J, Wang X, Towne V, Zhao Q Clin Vaccine Immunol. 2009; 16(8):1095-104.

PMID: 19553551 PMC: 2725548. DOI: 10.1128/CVI.00085-09.


A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.

Hu D, Cui J, Omoe K, Sashinami H, Yokomizo Y, Shinagawa K Infect Immun. 2004; 73(1):174-80.

PMID: 15618152 PMC: 538976. DOI: 10.1128/IAI.73.1.174-180.2005.


References
1.
KARAKAWA W, Young D . Immunological specificity of heat-stable opsonins in immune and nonimmune sera and their interaction with non-encapsulated and encapsulated strains of Staphylococcus aureus. Infect Immun. 1979; 25(1):175-86. PMC: 414435. DOI: 10.1128/iai.25.1.175-186.1979. View

2.
Espersen F, Frimodt-Moller N . Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med. 1986; 146(6):1118-21. View

3.
Bayer A, Tillman D, Concepcion N, Guze L . Clinical value of teichoic acid antibody titers in the diagnosis and management of the staphylococcemias. West J Med. 1980; 132(4):294-300. PMC: 1272065. View

4.
Shayegani M, Hisatsune K, MUDD S . Cell Wall Component Which Affects the Ability of Serum to Promote Phagocytosis and Killing of Staphylococcus aureus. Infect Immun. 1970; 2(6):750-6. PMC: 416086. DOI: 10.1128/iai.2.6.750-756.1970. View

5.
HUMPHREYS D, Wheat L, White A . Staphylococcal heat-stable opsonins. J Lab Clin Med. 1974; 84(1):122-8. View